Literature DB >> 9452934

Protective effects of neurosteroids against NMDA-induced seizures and lethality in mice.

B Budziszewska1, J Siwanowicz, M Leśkiewicz, L Jaworska-Feil, W Lasoń.   

Abstract

The effects of some neurosteroids on N-methyl-D-aspartic acid (NMDA)-induced seizures were examined in mice. Intraperitoneal (i.p.) administration of 5 alpha-pregnan-3 alpha-ol-20-one (5, 10 and 20 mg/kg). 5 beta-pregnan-3 alpha-ol-20-one (10 and 20 mg/kg), 5 alpha-pregnan-3 alpha-ol-11,20-dione (15 mg/kg), 5 alpha-androstan-3 alpha-ol-17-one (10 mg/kg) and dehydroepiandrosterone sulfate (25 mg/kg) significantly increased the dose of NMDA necessary to induce clonic convulsions in 50% of the tested animals (CD50). Furthermore, 5 alpha-pregnan-3 alpha-ol-20-one, 5 beta-pregnan-3 alpha-ol-20-one, 5 alpha-pregnan-3 alpha-ol-11,20-dione and 5 alpha-androstan-3 alpha-ol-17-one also protected the mice against NMDA-induced mortality. Importantly, it is only at the highest doses that neurosteroids impair motor performance of the animals, as estimated by a rotorod equilibrium procedure. The other neurosteroids tested, such as 5 alpha-pregnan-3 beta-ol-20-one (5-20 mg/kg), 5 alpha-pregnan-3 alpha,21-diol-20-one (10 and 15 mg/kg), 5 alpha-pregnan-3,20-dione (15 mg/kg) and pregnenolone sulfate (12.5-100 mg/kg) had no significant effects on the measured parameters. In another set of experiments, we evaluated the effects of neurosteroids on D-[3H]-aspartate release from rat hippocampal slices. None of the neurosteroids tested exerted a significant effect on basal D-[3H]-aspartate release. On the other hand, K(+)-stimulated D-[3H]-aspartate release was significantly attenuated by 5 alpha-pregnan-3 alpha-ol-20-one, 5 beta-pregnan-3 alpha-ol-20-one, alphaxalone, pregnenolone sulfate and dehydroepiandrosterone sulfate. The effect of 5 alpha-pregnan-3 alpha-ol-20-one was the most potent and was distinctly concentration-dependent, whereas the other compounds were effective only at the highest concentrations used. The above results indicate that some neurosteroids administered in non-sedative doses can protect mice against NMDA-induced seizures and mortality; furthermore, they inhibit D-[3H]-aspartate release in rat hippocampal slices.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452934     DOI: 10.1016/s0924-977x(97)00037-0

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  6 in total

1.  Diminished allopregnanolone enhancement of GABA(A) receptor currents in a rat model of chronic temporal lobe epilepsy.

Authors:  Z Mtchedlishvili; E H Bertram; J Kapur
Journal:  J Physiol       Date:  2001-12-01       Impact factor: 5.182

Review 2.  Neuroactive steroids for the treatment of status epilepticus.

Authors:  Michael A Rogawski; Carlos M Loya; Kiran Reddy; Dorota Zolkowska; Christoph Lossin
Journal:  Epilepsia       Date:  2013-09       Impact factor: 5.864

Review 3.  Pregnenolone sulfate as a modulator of synaptic plasticity.

Authors:  Conor C Smith; Terrell T Gibbs; David H Farb
Journal:  Psychopharmacology (Berl)       Date:  2014-07-06       Impact factor: 4.530

4.  Neuroprotective actions of neurosteroids.

Authors:  Kinga K Borowicz; Barbara Piskorska; Monika Banach; Stanislaw J Czuczwar
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-11       Impact factor: 5.555

5.  Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice.

Authors:  Dubravka Svob Strac; Josipa Vlainic; Janko Samardzic; Julija Erhardt; Zeljka Krsnik
Journal:  Drug Des Devel Ther       Date:  2016-03-21       Impact factor: 4.162

6.  Neurosteroids and Seizure Activity.

Authors:  Barbara Miziak; Magdalena Chrościńska-Krawczyk; Stanisław J Czuczwar
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.